Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2011-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pbb.2011.01.020PMID 21295057PMCID PMC3129015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cortical development in typically developing children with symptoms of hyperactivity and impulsivity: support for a dimensional view of attention deficit hyperactivity disorder.

  2011cited by this paper
• Dynamic Network Connectivity: A new form of neuroplasticity.

  2010cited by this paper
• Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.

  2010influential reference
• Catecholamine modulators: lessons from nonhuman primates.

  2010cited by this paper
• Dopamine's Influence on Prefrontal Cortical Cognition: Actions and Circuits in Behaving Primates

  2010cited by this paper
• Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder.

  2009cited by this paper
• Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.

  2009cited by this paper
• Noradrenergic genotype predicts lapses in sustained attention.

  2009cited by this paper
• A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders

  2009cited by this paper
• Two types of dopamine neuron distinctly convey positive and negative motivational signals

  2009cited by this paper
• The −1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD

  2008cited by this paper
• Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat

  2008cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

  2008influential reference
• Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections.

  2008cited by this paper
• Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.

  2008cited by this paper
• Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys

  2008cited by this paper
• Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder.

  2008cited by this paper
• Guanfacine in Children with Autism and/or Intellectual Disabilities

  2008cited by this paper
• Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex

  2008cited by this paper
• Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation

  2007cited by this paper
• Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory

  2007cited by this paper
• Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness.

  2007cited by this paper
• Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD.

  2007cited by this paper
• Top-Down Versus Bottom-Up Control of Attention in the Prefrontal and Posterior Parietal Cortices

  2007cited by this paper
• Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications

  2007cited by this paper
• Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.

  2007cited by this paper
• Response to Comment on "Top-Down Versus Bottom-Up Control of Attention in the Prefrontal and Posterior Parietal Cortices"

  2007cited by this paper
• Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.

  2006influential reference
• AProspective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders

  2006cited by this paper
• Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans

  2006cited by this paper
• The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys.

  2005cited by this paper
• Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task

  2005cited by this paper
• Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD.

  2005cited by this paper
• Behavioral and Brain Functions

  2005cited by this paper
• Structural brain imaging of attention-deficit/hyperactivity disorder.

  2005cited by this paper
• Relationship of prefrontal connections to inhibitory systems in superior temporal areas in the rhesus monkey.

  2005cited by this paper
• Comparison of the Effects of Bilateral Orbital Prefrontal Cortex Lesions and Amygdala Lesions on Emotional Responses in Rhesus Monkeys

  2005cited by this paper
• Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys.

  2005cited by this paper
• Structural Magnetic Resonance Imaging of the Adolescent Brain

  2004cited by this paper
• Selective D2 Receptor Actions on the Functional Circuitry of Working Memory

  2004cited by this paper
• Inhibition and the right inferior frontal cortex.

  2004cited by this paper
• Protein Kinase C Overactivity Impairs Prefrontal Cortical Regulation of Working Memory

  2004cited by this paper
• Selective deficit in no‐go performance induced by blockade of prefrontal cortical &agr;2‐adrenoceptors in monkeys

  2003cited by this paper
• Additive wake-promoting actions of medial basal forebrain noradrenergic α1- and β-receptor stimulation.

  2003cited by this paper
• Additive wake-promoting actions of medial basal forebrain noradrenergic alpha1- and beta-receptor stimulation.

  2003cited by this paper
• Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.

  2002cited by this paper
• Dopamine D4 Receptors Modulate GABAergic Signaling in Pyramidal Neurons of Prefrontal Cortex

  2002cited by this paper
• Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine

  2002cited by this paper
• Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.

  2002cited by this paper
• Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

  2002cited by this paper
• Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder.

  2002cited by this paper
• Evidence for a dysfunctional prefrontal circuit in patients with an impulsive aggressive disorder

  2002cited by this paper
• A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.

  2001cited by this paper
• Locus coeruleus and regulation of behavioral flexibility and attention.

  2000influential reference
• Effects of guanfacine on three forms of distraction in the aging macaque.

  2000cited by this paper
• Methylphenidate Enhances Working Memory by Modulating Discrete Frontal and Parietal Lobe Regions in the Human Brain

  2000cited by this paper
• Through the Looking Glass: Differential Noradenergic Modulation of Prefrontal Cortical Function

  2000cited by this paper
• Local infusion of an α-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys

  1999cited by this paper
• Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.

  1999cited by this paper
• Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons.

  1998cited by this paper
• The phasic reward signal of primate dopamine neurons.

  1998cited by this paper
• Effects of methylphenidate on spatial working memory and planning in healthy young adults

  1997cited by this paper
• The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys.

  1997cited by this paper
• Networks related to the orbital and medial prefrontal cortex; a substrate for emotional behavior?

  1996cited by this paper
• Localization of dopamine D4 receptors in GABAergic neurons of the primate brain

  1996cited by this paper
• Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeys.

  1996cited by this paper
• Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam.

  1995cited by this paper
• Cellular basis of working memory.

  1995cited by this paper
• Comparison of the Binding Activities of Some Drugs on α2A, α2B and α2C‐Adrenoceptors and Non‐Adrenergic Imidazoline Sites in the Guinea Pig

  1995cited by this paper
• Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig.

  1995cited by this paper
• Different types of centrally acting antihypertensives and their targets in the central nervous system

  1994cited by this paper
• Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys.

  1994cited by this paper
• Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine.

  1993cited by this paper
• Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidine

  1993cited by this paper
• Effects of alpha 2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats.

  1991cited by this paper
• Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.

  1991cited by this paper
• Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system.

  1991cited by this paper
• Delineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compound.

  1991cited by this paper
• Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radiollgand binding: computer modelling reveals that guanfacine is an α2A-selective compound

  1991cited by this paper
• Effects of α2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats

  1991cited by this paper
• Gating of somatosensory input by human prefrontal cortex.

  1990cited by this paper
• The determinants of stress-induced activation of the prefrontal cortical dopamine system.

  1990cited by this paper
• The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes

  1988cited by this paper
• Frontal lesions and sustained attention.

  1987cited by this paper
• Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates.

  1987cited by this paper
• Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates.

  1985cited by this paper
• Perseveration induced by methylphenidate in children: preliminary findings.

  1982cited by this paper
• Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal.

  1980cited by this paper
• Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine.

  1979cited by this paper
• a2A-Adrenoceptors Strengthen Working MemoryNetworksby InhibitingcAMP-HCN Channel Signaling in Prefrontal Cortex

  year unknowncited by this paper

• Aniracetam restores the excitation-inhibition balance of neurotransmitters in the prefrontal cortex of mice with ADHD

  2026cites this paper
• Maternal immune activation in mice recapitulates features of attention-deficit/hyperactivity disorder (ADHD) in susceptible offspring.

  2026cites this paper
• Impulsivity and attentional dysfunction in DAT-AAA knock-in mice.

  2026cites this paper
• Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition compared with methylphenidate

  2026cites this paper
• Beyond dopamine: Broader neuromodulatory contributions in sign- and goal-tracking.

  2026cites this paper
• Norepinephrine and dopamine Imbalance in the medial frontal gyrus from patients with Alzheimer's disease

  2026cites this paper
• Neurobiologija poremećaja pažnje i hiperaktivnosti

  2025cites this paper
• An Adolescent with Undiagnosed Inattentive-Type Attention Deficit–Hyperactivity Disorder and Comorbid Migraine: A Case Report

  2025cites this paper
• Effects of methylphenidate on children with attention deficit hyperactivity disorder: a study using clinical and multimodal approaches including go/no-go task and functional near-infrared spectroscopy

  2025cites this paper
• Evaluating potential impact of monoamine oxidase A missense L32S on the function of the enzyme monoamine oxidase A using in silico prediction tools and molecular modeling

  2025cites this paper
• Verbal fluency tasks and attention problems in children with ADHD: evidence from fNIRS

  2025cites this paper
• Exercise-Based Interventions for ADHD: A Review of Modalities, Mechanisms, and Practical Applications.

  2025cites this paper
• High Mobility Group Box 1 Protein as a Biomarker in Adult Attention Deficit Hyperactivity Disorder

  2025cites this paper
• Guanfacine-Associated Anxiety in a Child Diagnosed With DMDD and ADHD: A Case Presentation.

  2025cites this paper
• Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance

  2025cites this paper
• The efficacy and safety of antidepressants as alternative treatment of attention-deficit/hyperactivity disorder in pediatric populations

  2025cites this paper
• Nighttime caffeine intake increases motor impulsivity

  2025cites this paper
• Effects of aerobic exercise on executive function in children and adolescents with attention deficit hyperactivity disorder: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Single–dose methylphenidate induces shift in functional connectivity associated with positive longer term clinical response in adult attention–deficit/hyperactivity disorder

  2025cites this paper
• Association between dietary n-6/n-3 ratio and attention-deficit/hyperactivity disorder among American children and adolescents: findings from the National Health and Nutrition Examination Survey

  2025cites this paper
• Acute Supplementation of Soluble Mango Leaf Extract (Zynamite® S) Improves Mental Performance and Mood: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

  2025cites this paper
• Potential treatments for attention-deficit/hyperactivity disorder: a focus on Phase III trials

  2025cites this paper
• Therapeutic doses of methylphenidate following repetitive mild traumatic brain injury transiently disrupts risk/reward decision making in a sex dependent manner.

  2025cites this paper
• PHARMACOLOGICAL TREATMENT STRATEGIES FOR ADHD: A SYSTEMATIC REVIEW

  2025cites this paper
• Involvement of Dopamine in Cognitive Improvement by Aerobic Exercise.

  2025cites this paper
• Photobiomodulation as a therapeutic approach for attention-deficit/hyperactivity disorder in model rats

  2025cites this paper
• Sex-differences in catecholamine transporter expression in the rodent prefrontal cortex following repetitive mild traumatic brain injury and methylphenidate treatment

  2025cites this paper
• Can attention-deficit/hyperactivity disorder be considered a form of cerebellar dysfunction?

  2025cites this paper
• ADHD – A GLOBAL CHALLENGE. ARE WE CLOSER TO THE IDEAL THERAPY?

  2025cites this paper
• The Role of Gene–Gene Interaction Between ADRA2A and SLC6A2 Polymorphisms in Attention System and Treatment Outcomes for Children with ADHD

  2025cites this paper
• Nighttime Caffeine Intake Increases Motor Impulsivity

  2025cites this paper
• The neuromodulatory role of dopamine in improved reaction time by acute cardiovascular exercise

  2024cites this paper
• The effects of chiropractic adjustment on inattention, hyperactivity, and impulsivity in children with attention deficit hyperactivity disorder: a pilot RCT

  2024cites this paper
• Arousal dysregulation and executive dysfunction in attention deficit hyperactivity disorder (ADHD)

  2024cites this paper
• Atomoxetine reduces decisional impulsivity in human cocaine addiction.

  2024cites this paper
• The Potential Benefit of Atomoxetine for Treating Aggression and Violence in an Adult Patient with Down Syndrome and Intellectual Disability

  2024cites this paper
• ADHD - Treatment Options and Consequences of Neglect

  2024cites this paper
• Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder

  2024cites this paper
• Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance

  2024cites this paper
• Contextual memory engrams, and the neuromodulatory influence of the locus coeruleus

  2024cites this paper
• Posttraumatic anxiety-like behaviour in zebrafish is dose-dependently attenuated by the alpha-2A receptor agonist, guanfacine

  2024cites this paper
• New Advances in Attention-Deficit/Hyperactivity Disorder-like Dogs

  2024cites this paper
• Effects of voluntary exercise and electrical muscle stimulation on reaction time in the Go/No-Go task

  2024cites this paper
• The relation between MIND diet with odds of attention-deficit/hyperactivity disorder in Iranian children: a case-control study

  2024cites this paper
• Differential Roles of Key Brain Regions: Ventral Tegmental Area, Locus Coeruleus, Dorsal Raphe, Nucleus Accumbens, Caudate Nucleus, and Prefrontal Cortex in Regulating Response to Methylphenidate: Insights from Neuronal and Behavioral Studies in Freely Behaving Rats

  2024cites this paper
• FROM NEURONS TO BRAIN NETWORKS, PHARMACODYNAMICS OF STIMULANT MEDICATION FOR ADHD.

  2024cites this paper
• Sex-dependent perturbations in risky choice behavior and prefrontal tyrosine hydroxylase levels induced by repetitive mild traumatic brain injury.

  2024cites this paper
• Enhanced cognitive flexibility and phasic striatal dopamine dynamics in a mouse model of low striatal tonic dopamine

  2024cites this paper
• The Stress Phenotyping Framework: A multidisciplinary biobehavioral approach for assessing and therapeutically targeting maladaptive stress physiology

  2024influential citation
• Memory loss induced by lisdexamfetamine in the rat: A behavioral, electrophysiological, and histopathological Study.

  2024cites this paper
• Cortical alterations associated with lower response to methylphenidate in adults with ADHD

  2024cites this paper
• EEG Frequency Correlates with α2-Receptor Density in Parkinson’s Disease

  2024cites this paper
• The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project

  2024cites this paper
• Adult ADHD: What It Is and How to Assess and Treat It

  2024cites this paper
• Letter to the Editor Regarding “Book Review: The Prefrontal Cortex, Fifth Edition, Joaquín M. Fuster (Ed.), Academic Press (2015)”

  2024cites this paper
• Drug-Induced Cognitive Impairment

  2024cites this paper
• Novel pharmacological targets for GABAergic dysfunction in ADHD.

  2024cites this paper
• The known and unknown about attention deficit hyperactivity disorder (ADHD) genetics: a special emphasis on Arab population

  2024cites this paper
• An investigation of the acute effects of aerobic exercise on executive function and cortical excitability in adolescents with attention deficit hyperactivity disorder (ADHD)

  2024cites this paper
• A systematic review and activation likelihood estimation meta-analysis of fMRI studies on arousing or wake-promoting effects in Buddhist meditation

  2023cites this paper
• Dysregulated neuromodulation in the anterior cingulate cortex in chronic pain

  2023cites this paper
• The Effects of Sleep Deprivation, Acute Hypoxia, and Exercise on Cognitive Performance: A Multi-Experiment Combined Stressors Study.

  2023cites this paper
• Adult ADHD: it is old and new at the same time – what is it?

  2023cites this paper
• Contemporary diagnosis and treatment of conduct disorder in youth

  2023cites this paper
• Dysregulation of the autonomic nervous system in adult attention deficit hyperactivity disorder. A systematic review

  2023cites this paper
• Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine

  2023cites this paper
• Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study

  2023cites this paper
• Methylphenidate as a treatment option for substance use disorder: a transdiagnostic perspective

  2023cites this paper
• Impulsive choice in two different rat models of ADHD—Spontaneously hypertensive and Lphn3 knockout rats

  2023cites this paper
• Meta-analysis of the effects of physical activity on executive function in children and adolescents with attention deficit hyperactivity disorder

  2023cites this paper
• An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder

  2023cites this paper
• Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial

  2023cites this paper
• One single‐person bicycling enhances interpersonal cooperation via increasing interpersonal neural synchronization in left frontal cortex

  2023cites this paper
• A Novel Rat Model of ADHD-like Hyperactivity/Impulsivity after Delayed Reward Has Selective Loss of Dopaminergic Neurons in the Right Ventral Tegmental Area

  2023cites this paper
• The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review

  2023cites this paper
• Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia

  2023cites this paper
• Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.

  2023cites this paper
• Phenibut, Semax, and GIZh-290 Modulate Cortical mGluII Receptors in an Attention Deficit Model in Mice

  2023cites this paper
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

  2023cites this paper
• Current Perspectives on Attention-deficit Hyperactivity Disorder.

  2023cites this paper
• Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments.

  2023cites this paper
• Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats

  2023cites this paper
• Modafinil Administration to Preadolescent Rat Impairs Non-Selective Attention, Frontal Cortex D2 Expression and Mesolimbic GABA Levels

  2022cites this paper
• Updates in Pharmacologic Strategies in Adult Attention-Deficit/Hyperactivity Disorder.

  2022cites this paper
• Exploration heuristics decrease during youth

  2022cites this paper
• Nerve Stimulation: Sebuah Inovasi Terbaru sebagai Alternatif Pengobatan Gangguan Pemusatan Perhatian dan Hiperaktivitas

  2022cites this paper
• Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD

  2022cites this paper
• Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials

  2022cites this paper
• Better characterization of attention and hyperactivity/impulsivity in children with ADHD: The key to understanding the underlying white matter microstructure.

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• A Dopamine D1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory

  2022cites this paper
• A Review of ADHD and Childhood Trauma: Treatment Challenges and Clinical Guidance

  2022cites this paper
• Children with Attention Deficit Hyperactivity Disorder Are More Likely to Fail Growth Hormone Stimulation Testing than Children without Attention Deficit Hyperactivity Disorder: A Retrospective Chart Review

  2022cites this paper
• Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats

  2022cites this paper
• Distinct computational mechanisms underlying cognitive flexibility deficits in impulsivity and compulsivity

  2022cites this paper
• Prenatal nicotine alters development of the laterodorsal tegmentum: Possible role for attention-deficit/hyperactivity disorder and drug dependence

  2022cites this paper
• Nicotine and the developing brain: Insights from preclinical models.

  2022cites this paper
• Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder

  2022cites this paper
• Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

  2022cites this paper
• Attention Deficit Hyperactivity Disorder and Substance Use Disorder: A Narrative Review

  2022cites this paper